Transforming the lives of our patients and their families through innovative science and compassionate care.

Center Updates

National Academies of Sciences, Engineering and Medicine release comprehensive report on Food Allergy

The National Academies of Sciences, Engineering, and Medicine convened an expert, ad hoc committee to examine critical issues related to food allergy. The resulting report, released on November 30, 2016, Finding a Path to Safety in Food Allergy: Assessment of the Global Burden, Causes, Prevention, Management, and Public Policy, collects and evaluates the scientific evidence on the prevalence, origins, diagnosis, prevention, and management of food allergy and makes recommendations to policy makers, industry leaders, and others to bring about a safe environment for those with food allergy.

Following is a statement by Dr. Stephen Galli, the Mary Hewitt Loveless, M.D. Professor in the Stanford School of Medicine and Professor of Pathology and of Microbiology and Immunology, who served as a member of the Institute of Medicine committee that wrote this report.  

It was a privilege and honor to serve on this committee, and to work in producing the report with the other members of the committee, the dedicated and effective national academies staff, and the many private and federal sponsors of this important effort.

As described in the brief summary of the report that was released today, and as presented in substantial detail in the report itself, the committee concluded that the time is now to undertake a number of measures that, if enacted successfully, promise to improve markedly the quality of life of those suffering from food allergies. Succeeding in this effort will require the prompt and responsive cooperation of many stakeholders, including those federal and state agencies whose thoughtful work will be required to effect these changes. I encourage all those who are interested in the problem of food allergy to read the report and to do their part in encouraging the rapid implementation of the committee's recommendations.

 As important as implementing the report's recommendations will be in addressing this serious problem, finally succeeding in finding ways to effectively treat, or ideally to prevent the occurrence, of food allergies will require innovative research to advance our understanding of the origins of this disorder, and to devise better ways to prevent or treat it. I anticipate that, with the visionary leadership of Kari Nadeau, the Sean N. Parker Center for Allergy & Asthma Research at Stanford will continue to contribute importantly to the world-wide efforts, by talented investigators at many institutions, to bring relief to those suffering from this terrible disorder.


Hartman Family Foundation Challenge grant Matched

We met our match! We are thrilled to announce that we have raised $1.2 million to meet our challenge grant from the Hartman Family Foundation. Through the generous 1-to-1 match from Kim and Alan Hartman's Foundation and so many other generous donors, we raised a total of $2.4 million to directly support this major step to making a food allergy “vaccine” a reality.

 Read more about this inspiring support and peptide "vaccine" immunotherapy

Stay tuned for updates about this groundbreaking study to test an approach called peptide “vaccine” immunotherapy. Similar to a tuberculosis test, the food allergy “vaccine” would go under the skin to stimulate a specific set of immune cells and permanently reduce or suppress allergic reactions.  

“This could be a breakthrough for our field and we are grateful to the Hartman Foundation for making it possible through their gift,” said Dr. Kari Nadeau, Director of the Sean N. Parker Center for Allergy & Asthma Research at Stanford University.

Read more about Kim and Alan Hartman's inspiring support of the Center and Dr. Kari Nadeau's research.

94% of Center funding is provided by philanthropy. Ongoing support helps patients and families everyday by advancing the science and research for groundbreaking clinical trials, educating and disseminating protocol across the nation, building infrastructure for the Center, and so much more. To learn more about our important funding priorities, contact Lindsey Hincks

 Less 


The Sean N. Parker Center for Allergy and Asthma Research at Stanford University joins forces with Stanford's Division of Pulmonary and Critical Care Medicine

The Sean N. Parker Center for Allergy and Asthma Research at Stanford University has recently joined Stanford’s Division of Pulmonary and Critical Care Medicine (PCCM). Previously the Sean N. Parker Center for Allergy Research, the expanded Center now encompasses asthma research and patient care.

 More information about our integration with PCCM

“This is exciting news for our Center,” explains Center Director Dr. Kari Nadeau. “There are common mechanisms underlying allergy, asthma, and lung disease and by joining forces with PCCM, we can collaboratively advance our understanding of these diseases.”

The integration also strengthens PCCM’s research mission to support basic science and innovative clinical approaches for the prevention, early detection, diagnosis, and treatment of respiratory diseases and critical illnesses.

Under the leadership of Dr. Kari Nadeau, the Sean N. Parker Center for Allergy and Asthma Research conducts cutting-edge research to develop new innovative diagnostic tests and treatments for patients with asthma and allergies. The Center enrolls patients who represent a diverse group of ethnicities and socioeconomic backgrounds, offering equal opportunity to all eligible individuals with allergies and asthma.

PCCM, led by Division Chief Dr. Mark Nicolls, will now include the Sean N. Parker Center for Allergy and Asthma Research in addition to specialized programs for the treatment and management of interstitial lung disease, lung transplantation, cystic fibrosis, pulmonary hypertension, interventional pulmonology, lymphangioleiomyomatosis, lung nodule surveillance and cancer detection, and emphysema.

For more information about PCCM, please visit http://med.stanford.edu/pulmonary.html. For the latest information on trials currently being offered at Stanford and other institutions, please visit www.clinicaltrials.gov.

 Less 

In the News